<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="de">
	<id>https://ddn.pluspedia.org/w/index.php?action=history&amp;feed=atom&amp;title=Ezetimibe</id>
	<title>Ezetimibe - Versionsgeschichte</title>
	<link rel="self" type="application/atom+xml" href="https://ddn.pluspedia.org/w/index.php?action=history&amp;feed=atom&amp;title=Ezetimibe"/>
	<link rel="alternate" type="text/html" href="https://ddn.pluspedia.org/w/index.php?title=Ezetimibe&amp;action=history"/>
	<updated>2026-09-07T09:04:25Z</updated>
	<subtitle>Versionsgeschichte dieser Seite in PlusPedia</subtitle>
	<generator>MediaWiki 1.43.3</generator>
	<entry>
		<id>https://ddn.pluspedia.org/w/index.php?title=Ezetimibe&amp;diff=252464&amp;oldid=prev</id>
		<title>Mutter Erde: Änderungen von AkylaTripn (Diskussion) rückgängig gemacht und letzte Version von Ossip Groth wiederhergestellt</title>
		<link rel="alternate" type="text/html" href="https://ddn.pluspedia.org/w/index.php?title=Ezetimibe&amp;diff=252464&amp;oldid=prev"/>
		<updated>2011-12-05T09:05:58Z</updated>

		<summary type="html">&lt;p&gt;Änderungen von &lt;a href=&quot;/wiki/Spezial:Beitr%C3%A4ge/AkylaTripn&quot; title=&quot;Spezial:Beiträge/AkylaTripn&quot;&gt;AkylaTripn&lt;/a&gt; (&lt;a href=&quot;/w/index.php?title=Benutzer_Diskussion:AkylaTripn&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;Benutzer Diskussion:AkylaTripn (Seite nicht vorhanden)&quot;&gt;Diskussion&lt;/a&gt;) rückgängig gemacht und letzte Version von &lt;a href=&quot;/wiki/Benutzer:Ossip_Groth&quot; title=&quot;Benutzer:Ossip Groth&quot;&gt;Ossip Groth&lt;/a&gt; wiederhergestellt&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;de&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Nächstältere Version&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Version vom 5. Dezember 2011, 09:05 Uhr&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l2&quot;&gt;Zeile 2:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Zeile 2:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{| class=&amp;quot;wikitable&amp;quot; |&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{| class=&amp;quot;wikitable&amp;quot; |&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Freie Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Freie Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| align=&quot;left&quot; width=&quot;800&quot; |&amp;lt;ref name=&quot;PMID18522826&quot;&amp;gt;Ezetimibe blocks internalization of the NPC1L1/cholesterol complex. Cell Metab 7(6):469-71 (2008) PMID 18522826 &amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| align=&quot;left&quot; width=&quot;800&quot; |&amp;lt;ref name=&quot;PMID18522826&quot;&amp;gt;Ezetimibe blocks internalization of the NPC1L1/cholesterol complex. Cell Metab 7(6):469-71 (2008) PMID 18522826 &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18591835&quot;&amp;gt;Ezetimibe, a selective inhibitor of the transport of cholesterol. Intern Med 47(13):1165-70 (2008) PMID 18591835 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15887425&quot;&amp;gt;A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial. Mayo Clin Proc 80(5):587-95 (2005) PMID 15887425 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18375999&quot;&amp;gt;Use of ezetimibe in the United States and Canada. N Engl J Med 358(17):1819-28 (2008) PMID 18375999 &lt;/ins&gt;&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Wichtige Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Wichtige Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Mutter Erde</name></author>
	</entry>
	<entry>
		<id>https://ddn.pluspedia.org/w/index.php?title=Ezetimibe&amp;diff=252430&amp;oldid=prev</id>
		<title>AkylaTripn am 4. Dezember 2011 um 23:38 Uhr</title>
		<link rel="alternate" type="text/html" href="https://ddn.pluspedia.org/w/index.php?title=Ezetimibe&amp;diff=252430&amp;oldid=prev"/>
		<updated>2011-12-04T23:38:36Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;de&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Nächstältere Version&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Version vom 4. Dezember 2011, 23:38 Uhr&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l2&quot;&gt;Zeile 2:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Zeile 2:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{| class=&amp;quot;wikitable&amp;quot; |&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{| class=&amp;quot;wikitable&amp;quot; |&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Freie Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Freie Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| align=&quot;left&quot; width=&quot;800&quot; |&amp;lt;ref name=&quot;PMID18522826&quot;&amp;gt;Ezetimibe blocks internalization of the NPC1L1/cholesterol complex. Cell Metab 7(6):469-71 (2008) PMID 18522826 &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18591835&quot;&amp;gt;Ezetimibe, a selective inhibitor of the transport of cholesterol. Intern Med 47(13):1165-70 (2008) PMID 18591835 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15887425&quot;&amp;gt;A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial. Mayo Clin Proc 80(5):587-95 (2005) PMID 15887425 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18375999&quot;&amp;gt;Use of ezetimibe in the United States and Canada. N Engl J Med 358(17):1819-28 (2008) PMID 18375999 &lt;/del&gt;&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| align=&quot;left&quot; width=&quot;800&quot; |&amp;lt;ref name=&quot;PMID18522826&quot;&amp;gt;Ezetimibe blocks internalization of the NPC1L1/cholesterol complex. Cell Metab 7(6):469-71 (2008) PMID 18522826 &amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Wichtige Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Wichtige Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>AkylaTripn</name></author>
	</entry>
	<entry>
		<id>https://ddn.pluspedia.org/w/index.php?title=Ezetimibe&amp;diff=37302&amp;oldid=prev</id>
		<title>Ossip Groth am 19. März 2010 um 17:28 Uhr</title>
		<link rel="alternate" type="text/html" href="https://ddn.pluspedia.org/w/index.php?title=Ezetimibe&amp;diff=37302&amp;oldid=prev"/>
		<updated>2010-03-19T17:28:06Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;de&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Nächstältere Version&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Version vom 19. März 2010, 17:28 Uhr&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l2&quot;&gt;Zeile 2:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Zeile 2:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{| class=&amp;quot;wikitable&amp;quot; |&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{| class=&amp;quot;wikitable&amp;quot; |&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Freie Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Freie Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| align=&quot;left&quot; width=&quot;800&quot; |&amp;lt;ref name=&quot;PMID18522826&quot;&amp;gt;Ezetimibe blocks internalization of the NPC1L1/cholesterol complex. Cell Metab 7(6):469-71 (2008) PMID 18522826 &amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| align=&quot;left&quot; width=&quot;800&quot; |&amp;lt;ref name=&quot;PMID18522826&quot;&amp;gt;Ezetimibe blocks internalization of the NPC1L1/cholesterol complex. Cell Metab 7(6):469-71 (2008) PMID 18522826 &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18591835&quot;&amp;gt;Ezetimibe, a selective inhibitor of the transport of cholesterol. Intern Med 47(13):1165-70 (2008) PMID 18591835 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID15887425&quot;&amp;gt;A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial. Mayo Clin Proc 80(5):587-95 (2005) PMID 15887425 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&quot;PMID18375999&quot;&amp;gt;Use of ezetimibe in the United States and Canada. N Engl J Med 358(17):1819-28 (2008) PMID 18375999 &lt;/ins&gt;&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Wichtige Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Wichtige Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Ossip Groth</name></author>
	</entry>
	<entry>
		<id>https://ddn.pluspedia.org/w/index.php?title=Ezetimibe&amp;diff=23748&amp;oldid=prev</id>
		<title>Ossip Groth: Die Seite wurde neu angelegt: „Entstehender Artikel {| class=&quot;wikitable&quot; | | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Freie Übersichtsartikel&#039;&#039;&#039; | align=&quot;left&quot; width=&quot;800&quot; |&lt;re…“</title>
		<link rel="alternate" type="text/html" href="https://ddn.pluspedia.org/w/index.php?title=Ezetimibe&amp;diff=23748&amp;oldid=prev"/>
		<updated>2010-01-27T14:43:52Z</updated>

		<summary type="html">&lt;p&gt;Die Seite wurde neu angelegt: „&lt;a href=&quot;/wiki/Datei:Pptpdtjpg1.png&quot; title=&quot;Datei:Pptpdtjpg1.png&quot;&gt;miniatur|Entstehender Artikel&lt;/a&gt; {| class=&amp;quot;wikitable&amp;quot; | | bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Freie Übersichtsartikel&amp;#039;&amp;#039;&amp;#039; | align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot; |&amp;lt;re…“&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Neue Seite&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[Datei:pptpdtjpg1.png|miniatur|Entstehender Artikel]]&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; |&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Freie Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot; |&amp;lt;ref name=&amp;quot;PMID18522826&amp;quot;&amp;gt;Ezetimibe blocks internalization of the NPC1L1/cholesterol complex. Cell Metab 7(6):469-71 (2008) PMID 18522826 &amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Wichtige Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Medline Suchterm/ Synonyme&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#00dfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Was ist das&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Struktur&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Physiologie&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Knockout&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Transgen&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Mutation&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Polymorphismus&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Genexpression&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Inhibitoren&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Agonisten&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Bibliographie ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{LinkWP_Miniartikel}}&lt;/div&gt;</summary>
		<author><name>Ossip Groth</name></author>
	</entry>
</feed>